Jeffery Peppercorn

Summary

Affiliation: University of North Carolina
Country: USA

Publications

  1. doi request reprint The dilemma of data-safety monitoring: provision of significant new data to research participants
    Jeffery Peppercorn
    Division of Hematology Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7305, USA
    Lancet 371:527-9. 2008
  2. ncbi request reprint Association between pharmaceutical involvement and outcomes in breast cancer clinical trials
    Jeffrey Peppercorn
    Division of Hematology Oncology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA
    Cancer 109:1239-46. 2007
  3. doi request reprint Genotype-guided adjuvant endocrine therapy: new tricks from an old drug?
    Jeffrey Peppercorn
    University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center CB 7305, 3009 Old Clinic Chapel Hill, NC 27514, USA
    Expert Rev Anticancer Ther 8:191-4. 2008
  4. pmc Clinical trials and medical care: defining the therapeutic misconception
    Gail E Henderson
    University of North Carolina at ChapelHill, Chapel Hill, North Carolina, United Statesof America
    PLoS Med 4:e324. 2007
  5. doi request reprint Quantifying the recruitment challenges with couple-based interventions for cancer: applications to early-stage breast cancer
    Steffany J Fredman
    University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Psychooncology 18:667-73. 2009
  6. doi request reprint Reporting of race and ethnicity in breast cancer research: room for improvement
    Kelly W Mitchell
    Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA
    Breast Cancer Res Treat 118:511-7. 2009
  7. doi request reprint Molecular subtypes in breast cancer evaluation and management: divide and conquer
    Jeffrey Peppercorn
    University of North Carolina, Chapel Hill, North Carolina, USA
    Cancer Invest 26:1-10. 2008
  8. ncbi request reprint Breast cancer in young women: a new color or a different shade of pink?
    Jeffrey Peppercorn
    J Clin Oncol 26:3303-5. 2008
  9. ncbi request reprint Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: results from Cancer and Leukemia Group B 9066
    Jeffrey Peppercorn
    Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
    Cancer 104:1580-9. 2005
  10. doi request reprint Fertility and menopausal outcomes in young breast cancer survivors
    Ann H Partridge
    Dana Farber Cancer Institute, Brigham and Women s Hospital, Boston, MA 02115, USA
    Clin Breast Cancer 8:65-9. 2008

Collaborators

Detail Information

Publications11

  1. doi request reprint The dilemma of data-safety monitoring: provision of significant new data to research participants
    Jeffery Peppercorn
    Division of Hematology Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7305, USA
    Lancet 371:527-9. 2008
  2. ncbi request reprint Association between pharmaceutical involvement and outcomes in breast cancer clinical trials
    Jeffrey Peppercorn
    Division of Hematology Oncology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA
    Cancer 109:1239-46. 2007
    ..In this study, the authors sought to evaluate the impact of this shift in funding from public to private sponsors on the nature of published breast cancer clinical research...
  3. doi request reprint Genotype-guided adjuvant endocrine therapy: new tricks from an old drug?
    Jeffrey Peppercorn
    University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center CB 7305, 3009 Old Clinic Chapel Hill, NC 27514, USA
    Expert Rev Anticancer Ther 8:191-4. 2008
    ....
  4. pmc Clinical trials and medical care: defining the therapeutic misconception
    Gail E Henderson
    University of North Carolina at ChapelHill, Chapel Hill, North Carolina, United Statesof America
    PLoS Med 4:e324. 2007
  5. doi request reprint Quantifying the recruitment challenges with couple-based interventions for cancer: applications to early-stage breast cancer
    Steffany J Fredman
    University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Psychooncology 18:667-73. 2009
    ....
  6. doi request reprint Reporting of race and ethnicity in breast cancer research: room for improvement
    Kelly W Mitchell
    Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA
    Breast Cancer Res Treat 118:511-7. 2009
    ..Low accrual of black subjects and failure to report accrual and outcomes by race in RCT may contribute to difficulty in understanding and overcoming health disparities in breast cancer...
  7. doi request reprint Molecular subtypes in breast cancer evaluation and management: divide and conquer
    Jeffrey Peppercorn
    University of North Carolina, Chapel Hill, North Carolina, USA
    Cancer Invest 26:1-10. 2008
  8. ncbi request reprint Breast cancer in young women: a new color or a different shade of pink?
    Jeffrey Peppercorn
    J Clin Oncol 26:3303-5. 2008
  9. ncbi request reprint Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: results from Cancer and Leukemia Group B 9066
    Jeffrey Peppercorn
    Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
    Cancer 104:1580-9. 2005
    ..The patients were randomized to receive either high-dose chemotherapy with autologous stem cell support (HDC) or intermediate-dose chemotherapy (IDC) in the adjuvant setting...
  10. doi request reprint Fertility and menopausal outcomes in young breast cancer survivors
    Ann H Partridge
    Dana Farber Cancer Institute, Brigham and Women s Hospital, Boston, MA 02115, USA
    Clin Breast Cancer 8:65-9. 2008
    ..We evaluated these outcomes among young breast cancer survivors in collaboration with the Young Survival Coalition, an international advocacy group for young women with breast cancer...
  11. ncbi request reprint Web-based survey of fertility issues in young women with breast cancer
    Ann H Partridge
    Dana Farber Cancer Institute, 44 Binney St, D1210, Boston, MA 02115, USA
    J Clin Oncol 22:4174-83. 2004
    ..Young women with breast cancer often seek advice about whether treatment will affect their fertility. We sought to gain a better understanding of women's attitudes about fertility and how these concerns affect decision making...